MatthewMHsiehMD

Hematologic Oncology

Clinical Research at NIH

Dr. Hsieh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9000 Rockville Pike
Bldg 10
Bethesda, MD 20892
Phone+1 301-402-7687

Fax+1 301-480-8975

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 1998 - 2001
University of Vermont College of MedicineClass of 1998

PubMed

Kidney function after nonmyeloablative hematopoietic cell transplant for sickle cell disease.
Emily Limerick, Matthew M Hsieh, Mauricio Barretto, Neal Jeffries, Clarissa Diamantidis
Bone Marrow Transplantation. 2025-03-22
A machine learning-based workflow for predicting transplant outcomes in patients with sickle cell disease.
Haiou Li, Vandana Sachdev, Xin Tian, My-Le Nguyen, Matthew Hsieh
British Journal of Haematology. 2025-03-01
Two Nonmyeloablative HLA-Matched Related Donor Allogeneic Hematopoietic Cell Transplantation Regimens in Patients with Severe Sickle Cell Disease.
Zaina Inam, Neal Jeffries, Mary Link, Wynona Coles, Priscilla Pollack
Transplantation and Cellular Therapy. 2025-02-24

Abstracts/Posters

CRISPR-Cas9 Genome Editing of _-Globin Promoters in Human Hematopoietic Stem Cells to Induce Erythrocyte Fetal Hemoglobin for Treatment of _-Hemoglobinopathies
Matthew Hsieh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor
Matthew Hsieh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019